Treatment of relapsed and refractory multiple myeloma

The therapeutic strategy for relapsed and refractory multiple myeloma (RRMM) integrates a holistic approach regarding patient, disease, and drug-related factors. Patient-related factors include age, frailty status, and underlying comorbidities, especially cardiovascular and renal diseases and periph...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Hyun, Kim, Sung-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386890/
https://www.ncbi.nlm.nih.gov/pubmed/32719176
http://dx.doi.org/10.5045/br.2020.S008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386890/
https://www.ncbi.nlm.nih.gov/pubmed/32719176
http://dx.doi.org/10.5045/br.2020.S008

Ejemplares similares